kongre.net
Welcome to kongre.net
CT
ConferenceIn person

19th Clinical Trials on Alzheimer's Disease (CTAD)

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net
Welcome to kongre.net
Official website (opens in a new tab)

Programme

Published

3 sessions across 3 days

Browse programme

Registration

Registration is handled by the organiser

Go to registration(opens in a new tab)

Key facts

19th Clinical Trials on Alzheimer's Disease (CTAD) is a conference held 16 – 19 November 2026 in Boston, United States of America.

Dates:
16 – 19 November 2026
Format:
In person
Venue:
Boston, United States of America
Subjects:
Medical & Health Sciences, Clinical Medicine, Neurology, AI (Artificial Intelligence)
Official website:
ctad-alzheimer.com
The 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference is a premier global forum dedicated exclusively to Alzheimer's disease clinical research. Designed by and for AD researchers, CTAD focuses on clinical research dialogue, collaboration, and international advancements in the field.

Objectives

To prioritize substantive, clinical research-focused dialogue and collaboration, facilitate impactful international collaborations, and advance the global Alzheimer's disease research agenda.

Who should attend

AD researchers, international experts, clinicians, industry scientists, and regulatory experts.

Programme highlights

View full programme

Keynote speakers

View speakers

Jeffrey Cummings, Geoffrey A. Kerchner, Susan Landau, Allan Levey

Venue & travel Boston, United States of AmericaVenue detailsOrganiser contact Sarah LickissContact detailsWho is going? See who is planning to attend and say you are goingSee who is going

Organiser and contact

Contact

Event secretary:
Sarah Lickiss
Email:
[email protected]

Advertisement

Related events